Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 3
This trial is looking at atezolizumab with trastuzumab emtansine after surgery to remove breast cancer.
It is for people with breast cancer that has a large number of the protein (HER2 positive).
Recruitment start: 7 May 2021
Recruitment end: 31 July 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Duncan Wheatley
Roche
Last reviewed: 21 Nov 2024
CRUK internal database number: 17462